Citicoline - OPKO

Drug Profile

Citicoline - OPKO

Alternative Names: Citoneurox; Cytidine diphosphate choline

Latest Information Update: 23 Feb 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator OPKO Health
  • Class Neuroprotectants; Nootropics; Pyrimidine nucleotides; Small molecules; Trimethyl ammonium compounds
  • Mechanism of Action Hydroxy radical formation inhibitors; Phosphatidylcholine stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Neurological disorders; Stroke

Most Recent Events

  • 21 Oct 2013 OPKO receives final marketing approval from Agencia Espanola de Medicamentos y Productos Sanitarios for citicoline in Spain
  • 24 Jul 2013 Registered for Neurological disorders in Spain (IM)
  • 24 Jul 2013 Registered for Neurological disorders in Spain (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top